Glenmede Trust’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
+5,569
New +$406K ﹤0.01% 1040
2026
Q1
Sell
-2,639
Closed -$209K 1551
2025
Q4
$209K Buy
+2,639
New +$202K ﹤0.01% 1271
2025
Q1
$362K Sell
4,755
-2,581
-35% -$192K ﹤0.01% 1012
2024
Q4
$485K Sell
7,336
-5,007
-41% -$351K ﹤0.01% 943
2024
Q3
$861K Sell
12,343
-11,196
-48% -$673K ﹤0.01% 760
2024
Q2
$1.24M Buy
+23,539
New +$1.43M 0.01% 648

Other funds holding SOLV

Glenmede Trust's SOLV Position: Q2 2026 in Review

Glenmede Trust opened a new position in Solventum (SOLV) in Q2 2026: 5,569 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #1040 among its holdings. This is a return to the name: Glenmede Trust previously reported a position in SOLV as recently as Q4 2025.

Glenmede Trust first reported a position in SOLV in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.24M in Q2 2024. 881 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Glenmede Trust held 5,569 shares of Solventum worth $430K as of Q2 2026.
  • Solventum was a new Glenmede Trust position in Q2 2026.
  • Solventum made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1040 holding.
  • Glenmede Trust first reported a position in Solventum in Q2 2024 and has held it in 6 quarters since.
  • Glenmede Trust's Solventum position peaked at $1.24M in Q2 2024.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.